Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Long-Term Investments
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Long-Term Investments
¥1.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Long-Term Investments
¥772.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Long-Term Investments
¥2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
40%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Long-Term Investments
¥13.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
60%
|
CAGR 10-Years
58%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Long-Term Investments
¥1.4B
|
CAGR 3-Years
47%
|
CAGR 5-Years
31%
|
CAGR 10-Years
32%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Long-Term Investments
¥1.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View
Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., nestled in the heart of Fujian Province, China, is a firm steeped in history and tradition, yet thriving in today’s modern pharmaceutical landscape. The company is best known for its signature product, Pientzehuang Pills, a centuries-old traditional Chinese medicine believed to offer hepatoprotective and detoxifying properties. Rooted in ancient formulations, Pientzehuang Pills are celebrated for their efficacy in addressing liver ailments and enhancing overall vitality. This has secured their place as a staple in Chinese households, maintaining cultural resonance while appealing to a broader audience through the global rise in demand for alternative medicine. The firm operates with a delicate balance, integrating traditional Chinese medicine practices with increasingly sophisticated production technologies to ensure quality consistency and scalability. Zhangzhou Pientzehuang leverages its brand heritage and expertise in traditional herbal remedies to drive revenue. The company has adeptly positioned itself within both domestic and international markets, capitalizing on the growing interest in holistic health approaches. By focusing on research and development, the company continues to innovate, expanding its product line to include health supplements and preventive solutions that cater to modern health challenges. Its strategic distribution channels, including hospitals, pharmacies, and online platforms, enable broad market penetration, ensuring robust sales growth. This dual strategy of preserving the traditional while embracing the modern allows the company to keep its legacy relevant in a competitive pharmaceutical industry, thereby securing its stronghold in the market and ensuring sustained financial performance.
See Also
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments?
Long-Term Investments
1.4B
CNY
Based on the financial report for Sep 30, 2025, Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments amounts to 1.4B CNY.
What is Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
9%
Over the last year, the Long-Term Investments growth was 78%. The average annual Long-Term Investments growth rates for Zhangzhou Pientzehuang Pharmaceutical Co Ltd have been 26% over the past three years , 6% over the past five years , and 9% over the past ten years .